𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response of metastatic breast cancer to trastuzumab?

✍ Scribed by Diana M Barnes; David W Miles


Book ID
117312412
Publisher
The Lancet
Year
2000
Tongue
English
Weight
61 KB
Volume
355
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of ERBB2 amplicon size and genom
✍ Larry E. Morrison; Susan S. Jewell; Lydia Usha; Beth A. Blondin; Ruta D. Rao; Bi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract Trastuzumab is widely used for advanced breast cancer patients with __ERBB2__‐amplified tumors. Nevertheless, over half of these patients do not have an objective response. One reason may be altered expression of genes that might compensate for __ERBB2__ inhibition. We previously mapped